Shared by
beno
Fundamentals
As of: October 29th
Shares Outstanding: 17.2m
Cash: 17.8m
Current liabilities: 0.907m
Current ratio: 20
NWC (total current assets - total current liabilities): 17.282m
Accumulated deficit: 167m
Book value per share (Stock holder equity / Shares outstanding): 1.01
Monthly Burn rate (net cash used in operating activities / months): 213k
Estimated current cash: 17.3m
Baby Shelf Exemption price per share: 4.36
Catalysts / News / Painting the picture
-Dec 5th: Cassava Sciences Announces Additional Positive Phase 2a Clinical Data in Alzheimers Disease at CTAD 2019
-PR in early December / late November that caused a technical rally
Technical Analysis
-Filled gap from mid-2018 all the way to 6.50
-Levels: 5, 5.30, 5.50, 5.90, 6.3, 6.80, 7.20
-Not backside anymore, front side again
Original Plan / Strategy
First Test Long of 7 - 6.95 level
Review
This was One Good Trade, cut my last lot right before break down
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-01-02 15:01:09 | SAVA | buy | $7.010 | long |
| 2020-01-02 15:01:09 | SAVA | buy | $6.990 | long |
| 2020-01-02 15:01:09 | SAVA | buy | $6.980 | long |
| 2020-01-02 15:01:09 | SAVA | buy | $6.970 | long |
| 2020-01-02 15:02:02 | SAVA | sell | $7.060 | long |
| 2020-01-02 15:03:45 | SAVA | sell | $7.090 | long |
| 2020-01-02 15:03:52 | SAVA | sell | $7.110 | long |
| 2020-01-02 15:12:14 | SAVA | sell | $7.040 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!